Erymax 250mg (Erythromycin Delayed-Release 250 mg)
Pill with imprint Erymax 250mg is Orange / Clear, Capsule-shape and has been identified as Erythromycin Delayed-Release 250 mg. It is supplied by Midlothian Laboratories.
Erythromycin is used in the treatment of bronchitis; bowel preparation; bacterial endocarditis prevention; bartonellosis; otitis media and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Erythromycin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Erymax 250mg
Erythromycin Delayed-Release
- Imprint
- Erymax 250mg
- Strength
- 250 mg
- Color
- Orange / Clear
- Size
- 22.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Macrolides
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Midlothian Laboratories
- National Drug Code (NDC)
- 68308-0250
- Inactive Ingredients
-
FD&C Yellow No. 6,
titanium dioxide
Note: Inactive ingredients may vary.
More about erythromycin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 53 Reviews
- Drug class: macrolides
Consumer resources
- Patient Information
- Erythromycin (Advanced Reading)
- Erythromycin Intravenous (Advanced Reading)
- Erythromycin Delayed-Release Tablets and Capsules
- Erythromycin Injection
- ... +2 more
- Other brands
- Erythrocin, Ery-Tab, EryPed, Ilosone, ... +4 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.